University of Limerick
Svard_2016_Thermodynamic.pdf (793.74 kB)

Thermodynamic stability analysis of tolbutamide polymorphs and solubility in organic solvents

Download (793.74 kB)
journal contribution
posted on 2018-10-15, 15:22 authored by Michael Svärd, Masood Valavi, Dikshitkumar Khamar, Manuel Kuhs, Åke C. Rasmuson
Melting temperatures and enthalpies of fusion have been determined by differential scanning calorimetry (DSC) for 2 polymorphs of the drug tolbutamide: FIH and FV. Heat capacities have been determined by temperature-modulated DSC for 4 polymorphs: FIL, FIH, FII, FV, and for the supercooled melt. The enthalpy of fusion of FII at its melting point has been estimated from the enthalpy of transition of FII into FIH through a thermodynamic cycle. Calorimetric data have been used to derive a quantitative polymorphic stability relationship between these 4 polymorphs, showing that FII is the stable polymorph below approximately 333 K, above which temperature FIH is the stable form up to its melting point. The relative stability of FV is well below the other polymorphs. The previously reported kinetic reversibility of the transformation between FIL and FIH has been verified using in situ Raman spectroscopy. The solid-liquid solubility of FII has been gravimetrically determined in 5 pure organic solvents ( methanol, 1-propanol, ethyl acetate, acetonitrile, and toluene) over the temperature range 278 to 323 K. The ideal solubility has been estimated from calorimetric data, and solution activity coefficients at saturation in the 5 solvents determined. All solutions show positive deviation from Raoult's law, and all van't Hoff plots of solubility data are nonlinear. The solubility in toluene is well below that observed in the other investigated solvents. Solubility data have been correlated and extrapolated to the melting point using a semiempirical regression model. (C) 2016 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.



Journal of Pharmaceutical Sciences;105 (6), pp. 1901-1906





Other Funding information

SFI, Swedish Research Council


This is the author’s version of a work that was accepted for publication in Journal of Pharmaceutical Sciences. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Journal of Pharmaceutical Sciences, 2016 , 105 (6), pp. 1901-1906,



Usage metrics

    University of Limerick


    No categories selected


    Ref. manager